These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25998890)

  • 21. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial.
    Chen SL; Santoso T; Zhang JJ; Ye F; Xu YW; Fu Q; Kan J; Paiboon C; Zhou Y; Ding SQ; Kwan TW
    J Am Coll Cardiol; 2011 Feb; 57(8):914-20. PubMed ID: 21329837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in Vessel Healing Between Sirolimus- and Everolimus-Eluting Stent Implantation for Bifurcation Lesions: The J-REVERSE Optical Coherence Tomography Substudy.
    Terashita D; Otake H; Shinke T; Murasato Y; Kinoshita Y; Yamawaki M; Takeda Y; Fujii K; Yamada S; Shimada Y; Yamashita T; Yumoto K; Hirata K
    Can J Cardiol; 2016 Mar; 32(3):384-90. PubMed ID: 26481078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of zotarolimus- versus everolimus-eluting stents in the treatment of coronary bifurcation lesions.
    Herrador JA; Fernandez JC; Guzman M; Aragon V
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1086-92. PubMed ID: 21793165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R
    Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan.
    Yanagi D; Shirai K; Takamiya Y; Fukuda Y; Kuwano T; Ike A; Mori K; Kubota K; Iwata A; Fujimi K; Kawamura A; Nishikawa H; Miller N; Zhang B; Tsuchiya Y; Urata H; Saku K
    J Cardiol; 2008 Apr; 51(2):89-94. PubMed ID: 18522781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
    Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting.
    Pan M; Medina A; Suárez de Lezo J; Romero M; Segura J; Martín P; Suárez de Lezo J; Hernandez E; Mazuelos F; Ojeda S
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1165-70. PubMed ID: 22511299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry.
    Damman P; Abdel-Wahab M; Möllmann H; Richardt G; Chevalier B; Barragan P; Tijssen JG; Underwood P; Hamm CW
    J Invasive Cardiol; 2012 Oct; 24(10):495-502. PubMed ID: 23043032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
    Tamura T; Kimura T; Morimoto T; Nakagawa Y; Furukawa Y; Kadota K; Tatami R; Kawai K; Sone T; Miyazaki S; Mitsudo K;
    EuroIntervention; 2011 Sep; 7(5):588-96. PubMed ID: 21930463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study.
    Rahman S; Leesar T; Cilingiroglu M; Effat M; Arif I; Helmy T; Leesar MA
    JACC Cardiovasc Interv; 2013 Sep; 6(9):923-31. PubMed ID: 23954062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
    Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
    J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents.
    Burzotta F; Trani C; Talarico GP; Tommasino A; Todaro D; Coluccia V; Pirozzolo G; Niccoli G; Leone AM; Porto I; Schiavoni G; Crea F
    Cardiovasc Revasc Med; 2013; 14(3):122-7. PubMed ID: 23453789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents.
    Claessen BE; Mehran R; Mintz GS; Weisz G; Leon MB; Dogan O; de Ribamar Costa J; Stone GW; Apostolidou I; Morales A; Chantziara V; Syros G; Sanidas E; Xu K; Tijssen JG; Henriques JP; Piek JJ; Moses JW; Maehara A; Dangas GD
    JACC Cardiovasc Interv; 2011 Sep; 4(9):974-81. PubMed ID: 21939937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everolimus- versus sirolimus-eluting stents for the treatment of unprotected left main coronary artery stenosis (results from the EXCELLENT registry).
    Park KW; Lim WH; Ahn HS; Kang SH; Han JK; Lee SE; Cho JH; Gwon HC; Lee SY; Rhew JY; Kim W; Chae IH; Kim HS
    Int J Cardiol; 2013 Oct; 168(3):2738-44. PubMed ID: 23623141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting).
    Hahn JY; Chun WJ; Kim JH; Song YB; Oh JH; Koo BK; Rha SW; Yu CW; Park JS; Jeong JO; Choi SH; Choi JH; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Kim HS; Gwon HC
    J Am Coll Cardiol; 2013 Oct; 62(18):1654-1659. PubMed ID: 23954335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial randomized comparison of strut coverage of everolimus- and first-generation sirolimus-eluting stents.
    Kim JS; Kim JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Can J Cardiol; 2015 Jun; 31(6):723-30. PubMed ID: 25882337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.